Company Description

Zylem Biosciences is a biotechnology company developing targeted medicines that modulate oxidative damage in human cells. Oxidative damage is implicated in many of the diseases that cause significant mortality and morbidity, including cancer and cardiovascular disease. It is also one of the prime causes of aging.